EVERMIL 5MG TABLET

About

Evermil 5mg Tablet contains Everolimus, a potent immunosuppressant and antineoplastic agent that functions as an inhibitor of the mammalian target of rapamycin (mTOR) pathway. This pathway is critical for cellular processes such as growth, proliferation, and angiogenesis. By inhibiting mTOR, Everolimus effectively suppresses the immune system, thereby preventing the rejection of transplanted organs. In the context of cancer, it interferes with the growth and spread of tumor cells by targeting specific signaling pathways essential for their survival and proliferation.

This medication is indicated for the prophylaxis of organ rejection in adult kidney and heart transplant recipients, typically in combination with other immunosuppressants. Furthermore, it is used in oncology for the treatment of advanced renal cell carcinoma, progressive neuroendocrine tumors of pancreatic origin, and subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Its broad application highlights its significance in both transplant medicine and targeted cancer therapy.

Uses

• Prevention of organ rejection in heart transplant recipients.
• Treatment of advanced renal cell carcinoma.
• Management of progressive neuroendocrine tumors.
• Therapy for subependymal giant cell astrocytoma.

Directions For Use

Take Evermil 5mg Tablet orally, once daily, at the same time each day, consistently with or without food. Swallow the tablet whole; do not crush, chew, or break it.

Benefits

• Prevents rejection of transplanted organs.
• Inhibits growth of specific cancer cells.
• Effective in managing certain tumor types.
• Offers a targeted therapeutic approach.
• Improves patient survival in oncology.
• Reduces the risk of graft loss in transplant.

Side Effects

• Mouth sores/ulcers
• Skin rash
• Weakness/fatigue
• Diarrhea
• Swelling (edema)
• Anemia
• High blood sugar
• High cholesterol
• Increased risk of infections
• Cough
• Protein in urine
• Pneumonitis

Safety Measures

• Alcohol - Alcohol consumption should be avoided as it may exacerbate side effects or interfere with the drug's metabolism.
• Pregnancy - Evermil is not recommended during pregnancy due to potential harm to the fetus. Women of childbearing potential must use effective contraception.
• Breastfeeding - Breastfeeding is not advised while taking Evermil as the drug may be excreted in breast milk and pose risks to the infant.
• Liver - Patients with hepatic impairment require careful monitoring and potential dose adjustments. Liver function tests should be performed regularly.
• Kidney - Use with caution in patients with renal impairment. While not primarily renally cleared, kidney function should be monitored, especially in transplant patients.
• Lung - Interstitial lung disease is a known risk; patients should be monitored for respiratory symptoms. Prompt medical attention is needed for new or worsening cough or dyspnea.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.